Ablative Solutions
Cardiovascular Devices
Overview
Ablative Solutions, Inc. is investigating alcohol-mediated renal denervation delivered using the Peregrine System™ Infusion Catheter to reduce blood pressure in patients with hypertension.
Funding and backers
Total raised
$133.4M
14 rounds on record
Latest round
$10.4M
Venture round · Nov 2025 · 11 mo ago
The money's age
Fresh money
11 months since the last round · not hiring
Momentum
20/100
fresh money
The story so fareach stage dated by its source: the company's releases, the press, registers, filings
Nov 14, 2025
Raised a round Venture round $10.4M · SEC Form D
Dec 18, 2024
Raised a round Venture round $37.2M · SEC Form D
Mar 31, 2023
Took on debt financing $29.3M · SEC Form D
Dec 28, 2018
Raised a round Venture round $54.5M · SEC Form D
Dec 20, 2017
Took on debt financing $4M · SEC Form D
Feb 21, 2017
Raised a round Venture round $11.4M · SEC Form D
Oct 30, 2015
Took on debt financing $2.5M · SEC Form D
Dec 30, 2013
Raised a round Venture round $14.6M · SEC Form D
Mar 26, 2013
Took on debt financing $8M · SEC Form D
Jun 14, 2012
Raised a round Venture round $5.4M · SEC Form D
Feb 1, 2012
Raised a round Venture round $990 · SEC Form D
Jan 11, 2012
Raised a round Venture round $500 · SEC Form D
Dec 15, 2011
Raised a round Venture round $5k · SEC Form D
Nov 17, 2011
Took on debt financing $3.1M · SEC Form D
Funding rounds
| Round | Date | Amount | Investors | Source |
|---|---|---|---|---|
| Venture round | Nov 2025 | $10.4M | — | SEC Form D |
| Venture round | Dec 2024 | $37.2M | — | SEC Form D |
| Debt Financing | Mar 2023 | $29.3M | — | SEC Form D |
| Venture round | Dec 2018 | $54.5M | — | SEC Form D |
| Debt Financing | Dec 2017 | $4M | — | SEC Form D |
| Venture round | Feb 2017 | $11.4M | — | SEC Form D |
| Debt Financing | Oct 2015 | $2.5M | — | SEC Form D |
| Venture round | Dec 2013 | $14.6M | — | SEC Form D |
| Debt Financing | Mar 2013 | $8M | — | SEC Form D |
| Venture round | Jun 2012 | $5.4M | — | SEC Form D |
| Venture round | Feb 2012 | $990 | — | SEC Form D |
| Venture round | Jan 2012 | $500 | — | SEC Form D |
| Venture round | Dec 2011 | $5k | — | SEC Form D |
| Debt Financing | Nov 2011 | $3.1M | — | SEC Form D |
Registers and programsofficial lists and records that name the company
| Legal entity | Ablative Solutions, Inc. | SEC Form D |
Founders and leadersfrom filings, registers and the company's site
Ronald BacheExecutive Officer, DirectorSEC Form D
Brian RaulsExecutive OfficerSEC Form D
Investors in similar startupsfunds that back the companies most like this one
Similar startupsby what they do, their industry and backers
About BaroPace™ ^ Early 1800's The important relationship between heart rate and blood pressure was identified by Jean Léonard Marie…
Puracath reduces catheter infection risks with UV tech. Streamlined disinfection process. Contact us in San Francisco, CA for details.
Procyrion Aortix™ is a catheter-deployed circulatory assist device for the millions of heart failure patients who are too sick for…
VitalPath is a leading medical device contract manufacturer 100% focused on complex catheter design, rapid prototyping, and full-scale ISO…
Developing innovative catheter technology to treat acute ischemic stroke, providing superior clinical outcomes in shorter procedural times.
ACES® from Pleural Dynamics is the first FDA-cleared implant designed for recurrent pleural effusions. Continuous relief without external…
Financials
Total raised
$180.2M
Latest round
Venture - Series Unknown
Funding rounds
14
Funding rounds
| Round | Announced | Amount | |
|---|---|---|---|
| Venture - Series Unknown | 2025 | $10.4M | Details |
| Venture - Series Unknown | 2024 | $37.2M | Details |
| Debt Financing | 2023 | $29.3M | Details |
| Venture - Series Unknown | 2018 | $54.5M | Details |
| Debt Financing | 2017 | $4M | Details |
| Venture - Series Unknown | 2017 | $11.4M | Details |
| Debt Financing | 2015 | $2.5M | Details |
| Venture - Series Unknown | 2013 | $14.6M | Details |
| Debt Financing | 2013 | $8M | Details |
| Venture - Series Unknown | 2012 | $5.4M | Details |
| Venture - Series Unknown | 2012 | $990 | Details |
| Venture - Series Unknown | 2012 | $500 | Details |
| Venture - Series Unknown | 2011 | $5k | Details |
| Debt Financing | 2011 | $3.1M | Details |
People
Ronald Bache
Executive Officer, Director
Brian Rauls
Executive Officer
Louis Cannon
Director
John Kerschen
Director
Benjamin Tsai
Director
Geoff Pardo
Director
Names and roles come from public filings, company registers and the company's own site. Is this you? Correct or remove · How we handle this data
Offices
Where the company hires and what each office is for
Cities
1
Hiring now
0
Countries
1
Wakefield
United States
HQ